Cwm, LLC Pharma Cyte Biotech, Inc. Put Options Transaction History
Cwm, LLC
- $33.3 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PMCB
# of Institutions
28Shares Held
563KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA127KShares$107,6120.0% of portfolio
-
Ayrton Capital LLC Westport, CT92.1KShares$78,2737.31% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$70,3170.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.9KShares$63,6810.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny49.8KShares$42,3300.0% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $17.6M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...